As of Mar 05
| +0.29 / +7.73%|
The 3 analysts offering 12-month price forecasts for Catalyst Pharmaceutical Partners Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 6.00. The median estimate represents a +73.27% increase from the last price of 4.04.
The current consensus among 3 polled investment analysts is to Buy stock in Catalyst Pharmaceutical Partners Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.